Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001470831-25-000409

Chief Financial Officer gave up 155 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Sullivan Christopher Ryan · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-10 Shares withheld for taxes : show line 1 in the form −155 $4.10 $636 17,338 D
Loading xslF345X05/form4.xml…